Self-Management Program for Stroke
(IPASS-R Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help individuals who have recently experienced a stroke manage their recovery more effectively. Delivered through telehealth, participants can join from home. The program focuses on enhancing confidence, daily activities, and overall quality of life. Participants will either engage in a new stroke-specific self-management program called Improving Participation after Stroke Self-Management Program (IPASS) or a general chronic disease management program, both led by professionals and peers. This trial suits those who have had a mild to moderate stroke within the last six months, have completed rehabilitation if needed, and are living at home with or without caregiver support. As an unphased trial, this study provides a unique opportunity to contribute to innovative stroke recovery research from the comfort of home.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this self-management program is safe for stroke patients?
Research has shown that the Improving Participation after Stroke Self-Management Program (IPASS) helps individuals enhance their lives following a stroke. The program aims to build self-confidence and support participation in daily activities. No safety concerns have been reported with this program. Offered through telehealth, IPASS does not involve medications or physical treatments, making medical side effects unlikely. The program focuses on teaching new skills and strategies, ensuring a safe process for participants.12345
Why are researchers excited about this trial?
Researchers are excited about the Self-Management Program for Stroke because it offers a new approach to helping stroke survivors regain their independence. Unlike traditional treatments that often focus on medical interventions, the IPASS program emphasizes self-management through a series of interactive, remote sessions led by occupational therapists and peer facilitators who have experienced stroke themselves. This peer support element can enhance motivation and engagement, making the recovery process more relatable and personalized. Additionally, the use of videoconferencing makes the program accessible to a wider audience, removing geographical barriers and allowing participants to engage from the comfort of their homes. Overall, IPASS could revolutionize how we support stroke survivors in their journey toward recovery.
What evidence suggests that the Improving Participation after Stroke Self-Management Program (IPASS) is effective for stroke recovery?
Research has shown that the Improving Participation after Stroke Self-Management Program (IPASS), which participants in this trial may receive, helps stroke survivors manage and engage in daily activities more effectively. One study found that participants felt more confident in handling life after a stroke, demonstrating improved self-efficacy. They also became better at returning to their normal routines, as measured by tools like the Reintegration to Normal Living Index. This suggests that IPASS could positively affect confidence, activity levels, and overall quality of life for people recovering from a stroke.12346
Who Is on the Research Team?
Anna E Boone, PhD, OTR/L
Principal Investigator
University of Missouri Occupational Therapy
Are You a Good Fit for This Trial?
This trial is for individuals aged 45-85 who had a mild or moderate stroke within the last 6 months, live in the community (not in skilled nursing facilities), can communicate in English, and can use videoconferencing with or without help. They should have finished any recommended inpatient rehab.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the IPASS-R intervention consisting of 6 weekly 90-minute sessions delivered via telehealth
Follow-up
Participants are monitored for self-efficacy, activity performance, and quality of life improvements
What Are the Treatments Tested in This Trial?
Interventions
- Improving Participation after Stroke Self-Management Program (IPASS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
University of Washington
Collaborator
University of Illinois at Chicago
Collaborator